GenSci to attend CPhI China 2007

GenSci will be attending the CPHI China 2007, China International Pharmaceutical Ingredients Fair, at the the Shanghai New International Expo Centre (SNIEC), Shanghai, China, on June 19 –June 21, 2007. GenSci's management executives and staff from International Commercial Development & Regulatory Affairs will be available on-site to answer questions about:

-GenSci and GenSci's products
-Partnering and business opportunities
-Further development of our business

We cordially invite all of our respected clients and professionals from all over the world who are interested in collaborating with us to visit GenSci at booth #3T23.

CPhI China，the leading and most comprehensive exhibition on pharmaceutical ingredients and allied industries in China，was launched in China in 2000. It attacts 17,885 visitors of which 3,616 international visitors and over 1000 exhibitors from 21 countries & regions in CPhI China 2006. ICSE China was launched in 2005 and P-MEC China in 2006. For more information, please visit http://www.cmpsinoexpo.com/cphi-china/.

GenSci (www.gensci-china.com) is the leading Chinese biopharmaceutical company that develops, manufactures and markets biological therapeutics focused on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients. The company is privately-held and headquartered in Changchun, China. Products include: Jintropin™ somatropin (rhGH for injection), Jintropin™ AQ somatropin liquid pen, Scimax™ filgrastim (rhG-CSF injection), Granmac™ molgramostim (rhGM-CSF for injection), Jintrotide™ (octreotide acetate for injection) and Jintrirelin™ (triptorelin acetate injection). For more information, visit www.gensci-china.com.

Contact: